Literature DB >> 32222968

BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages.

Brittany E Dong1, Hao Chen1, Kazuko Sakata1.   

Abstract

Deficiency of activity-induced expression of brain-derived neurotrophic factor (BDNF) disturbs neurotransmitter gene expression. Enriched environment treatment (EET) ameliorates the defects. However, how BDNF deficiency and EET affect the neurotransmitter gene expression differently across ages remains unclear. We addressed this question by determining the neurotransmitter gene expression across three life stages in wild-type and activity-dependent BDNF-deficient (KIV) mice. Mice received 2-months of standard control treatment (SCT) or EET at early-life development (ED: 0-2 months), young adulthood (2-4 months), and old adulthood (12-14 months) (N = 16/group). Half of these mice received additional 1-month SCT to examine persisting EET effects. High-throughput quantitative reverse transcription polymerase chain reaction measured expression of 81 genes for dopamine, adrenaline, serotonin, gamma aminobutyric acid, glutamate, acetylcholine, and BDNF systems in the frontal cortex (FC) and hippocampus. Results revealed that BDNF deficiency mostly reduced neurotransmitter gene expression, greatest at ED in the FC. EET increased expression of a larger number of genes at ED than adulthood, particularly in the KIV FC. Many genes down-regulated in KIV mice were up-regulated by EET, which persisted when EET was provided at ED (e.g., 5-hydroxytryptamine (serotonin) transporter [5HTT], ADRA1D, GRIA3, GABRA5, GABBR2). In both the regions, BDNF deficiency decreased the density of gene co-expression network specifically at ED, while EET increased the density and hub genes (e.g., GAT1, GABRG3, GRIN1, CHRNA7). These results suggest that BDNF deficiency, which occurs under chronic stress, causes neurotransmitter dysregulations prominently at ED, particularly in the FC. EET at ED may be most effective to normalize the dysregulations, providing persisting effects later in life. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. More information about the Open Science badges can be found at https://cos.io/our-services/open-science-badges/.
© 2020 International Society for Neurochemistry.

Entities:  

Keywords:  age-dependency; brain-derived neurotrophic factor (BDNF); early life; enriched environment; gene co-expression network; neurotransmitter genes

Mesh:

Substances:

Year:  2020        PMID: 32222968      PMCID: PMC7319906          DOI: 10.1111/jnc.15017

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  68 in total

Review 1.  Neurotrophins as synaptic modulators.

Authors:  M M Poo
Journal:  Nat Rev Neurosci       Date:  2001-01       Impact factor: 34.870

2.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

Authors:  C Hyman; M Hofer; Y A Barde; M Juhasz; G D Yancopoulos; S P Squinto; R M Lindsay
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

Review 3.  BDNF and activity-dependent synaptic modulation.

Authors:  Bai Lu
Journal:  Learn Mem       Date:  2003 Mar-Apr       Impact factor: 2.460

4.  Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.

Authors:  R F Alderson; A L Alterman; Y A Barde; R M Lindsay
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

5.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

6.  Maternal low-protein diet decreases brain-derived neurotrophic factor expression in the brains of the neonatal rat offspring.

Authors:  Gurdeep Marwarha; Kate Claycombe-Larson; Jared Schommer; Othman Ghribi
Journal:  J Nutr Biochem       Date:  2017-04-06       Impact factor: 6.048

7.  Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.

Authors:  C S Weickert; T M Hyde; B K Lipska; M M Herman; D R Weinberger; J E Kleinman
Journal:  Mol Psychiatry       Date:  2003-06       Impact factor: 15.992

8.  GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor.

Authors:  S Marty; B Berninger; P Carroll; H Thoenen
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

9.  BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

Authors:  H S Phillips; J M Hains; M Armanini; G R Laramee; S A Johnson; J W Winslow
Journal:  Neuron       Date:  1991-11       Impact factor: 17.173

10.  Mouse and rat BDNF gene structure and expression revisited.

Authors:  Tamara Aid; Anna Kazantseva; Marko Piirsoo; Kaia Palm; Tõnis Timmusk
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

View more
  6 in total

1.  Metabolomic Profiling and Neuroprotective Effects of Purslane Seeds Extract Against Acrylamide Toxicity in Rat's Brain.

Authors:  Ola M Farag; Reham M Abd-Elsalam; Hanan A Ogaly; Sara E Ali; Shymaa A El Badawy; Muhammed A Alsherbiny; Chun Guang Li; Kawkab A Ahmed
Journal:  Neurochem Res       Date:  2021-01-13       Impact factor: 3.996

2.  Hippocampal Iron Accumulation Impairs Synapses and Memory via Suppressing Furin Expression and Downregulating BDNF Maturation.

Authors:  Xue Bai; Yi Zhang; Yating Zhang; Shanshan Yao; Yiduo Cui; Lin-Hao You; Peng Yu; Yan-Zhong Chang; Guofen Gao
Journal:  Mol Neurobiol       Date:  2022-06-23       Impact factor: 5.682

Review 3.  Brain NMDA Receptors in Schizophrenia and Depression.

Authors:  Albert Adell
Journal:  Biomolecules       Date:  2020-06-23

4.  Environmental enrichment implies GAT-1 as a potential therapeutic target for stroke recovery.

Authors:  Yuhui Lin; Mengcheng Yao; Haiyin Wu; Feng Wu; Shiying Cao; Huanyu Ni; Jian Dong; Di Yang; Yanyu Sun; Xiaolin Kou; Jun Li; Hui Xiao; Lei Chang; Jin Wu; Yan Liu; Chunxia Luo; Dongya Zhu
Journal:  Theranostics       Date:  2021-01-27       Impact factor: 11.556

5.  Weak representation of awake/sleep states by local field potentials in aged mice.

Authors:  Daichi Konno; Yuji Ikegaya; Takuya Sasaki
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

Review 6.  Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions.

Authors:  Motohiro Okada; Yasuhiro Kawano; Kouji Fukuyama; Eishi Motomura; Takashi Shiroyama
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.